HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse
Most Cited Paper
in HIV Research and Treatment
18 Months Post-Publication
Class of 2026
“HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/hiv-research-and-treatment/2026/
Topics
HepB-CpG vaccine · HepB-alum vaccine · cytosine phosphoguanine adjuvant · aluminum hydroxide adjuvant · hepatitis B vaccine nonresponse · People living with HIV (PLHIV) · seroprotection response · antibody titer against HBsAg · hepatitis B surface antigen · Antiretroviral therapy · CD4 count · HIV viral load · 2-dose vaccine regimen · 3-dose vaccine regimen · vaccine noninferiority · Intramuscular administration · hepatitis B virus immunity · revaccination strategy
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited HIV Research and Treatment Papers, Class of 2026. https://pri.pepkio.com/top-papers/hiv-research-and-treatment/2026. Accessed 2026-07-21. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459